This document provides an overview of data loading and data entry for clinical trials. It discusses the types of data that data entry operators should be aware of, including medical terms and abbreviations. It describes the process of double data entry, where two operators independently enter the same data from case report forms to ensure accuracy. Common errors made during data entry are also outlined, such as spelling errors, numerical errors, and missed terms. The document provides remedial actions like developing a mock database for practice before production entry. It emphasizes the importance of leaving proper spacing between words and being careful to not change responses when tabbing between fields.
Clinical Data Management Interview Question Part 2ClinosolIndia
Embarking on a career in Clinical Data Management requires a thorough understanding of the intricacies involved in handling and processing clinical trial data. In this presentation, we explore key interview questions that shed light on the critical aspects of CDM, helping both aspiring professionals and seasoned experts stay abreast of industry trends and expectations.
Clinical Data Management Interview Question Part 2ClinosolIndia
Embarking on a career in Clinical Data Management requires a thorough understanding of the intricacies involved in handling and processing clinical trial data. In this presentation, we explore key interview questions that shed light on the critical aspects of CDM, helping both aspiring professionals and seasoned experts stay abreast of industry trends and expectations.
TSDP tells about the essential documents that are required for the #conduct of a clinical trial. For #regulatory medical writing training, contact hello@turacoz.in.
Explaining the importance of a database lock in clinical researchTrialJoin
One of the most crucial aspects of research is clinical data management or CDM. Proper CDM will generate results with excellent quality, integrity, and reliability. Quality data is essential in order to support the final conclusions of a certain study.
The person responsible for this area of research is called a clinical data manager. This job position can be filled by a PI, a study coordinator, or a CRA. No matter who fills this position at your site, data management has to be done promptly and correctly in order to generate the best results. Aside from all the other reasons why data management is so important, it’s also what determines the future IP (investigational product) development.
Clinical Data Management Plan_Katalyst HLSKatalyst HLS
Introduction to Data Management Plan in Clinical Data Management in Clinical Trials of Pharmaceuticals, Bio-Pharmaceuticals, Medical Devices, Cosmeceuticals and Foods.
Clinical data management (CDM) is a covered part in the clinical trial and most commonly used tools for the purpose of effectivity of clinical research
Electronic Data Capture & Remote Data CaptureCRB Tech
CRB Tech is one of the best leading Software Development Company in Pune. We are offering Software Development Services as well as IT Training including Java, Dot Net, SEO and Clinical Research training in pune.
How to prepare and handle a FDA Inspection. When the FDA conducts an audit of your company, you need to be prepared. This presentation shows you what to do when your are faced with a FDA Inspection. For more information go to http://compliance-insight.com/fda-483-warning-letters/fda-483-inspection/
In any work or process documents that are needed before initiation, Between or generally the end of the process just like in a clinical trial those “Documents which permit evaluation of the conduct of a trial and the quality of the data produced. It is given in the 8th section of the ICH-GCP.
CDM is defined as the process of collection, cleaning, and management of subject data in compliance with regulatory standards.
A database must be accurate, secure, reliable and ready for analysis.
CDMS is the tool for clinical data management.
RESPONSIBILITES OF CDM
STUDY SET UP (15%) - this includes all the activities that are done before at the starting of the study.
STUDY CONDUCT (60%)- this starts once a subject enrollment begins or with first patient‘s first visit.
STUDY CLOSEOUT (25%) -the data is final and ready for statistical analysis.
CASE REPORT FORM
Types of CRF
PAPER CRF
e-CRF
Data entry is a process of entering or transferring data from case report form ( paper or image ) to clinical data management system (electronic storage ).
optical mark reading (OMR)
Data entry may be entirely manual or partly computerized using optical character recognition (OCR).
The three basic types of data entry system:
(a) Local data entry system - data entry is done on site
(b) Central data entry system - data entry is done at data management centre from the received CRFs;
(c) Web based data entry system - data entry is done through web (secure link) using internet connection.
DATA CLEANING
MANAGING ADR DATA
ADR data are collected from clinical trials and marketed products.
All ADR are reported to clinical data management system or safety system.
During clinical trials-ADR information is also received through CRF or EDC.
These information are stored in clinical data management database.
DATABASE LOCK PROCESS
Data manager – data is accurate and complete
Clinical project manager – site activities are complete
Medical monitor - data is medically accurate
Biostatistician - data is ready for evaluation and analysis.
Data manager asks for the database to be locked .
Done through the company’s IT department.
Once locked, no data can be changed.
Signed process for locking the database is placed in Trial Master File (TMF)
Data base closure (database lock): The database closure for the study is done to ensure no manipulation of study data during final analysis.
DATABASE LOCK/FREEZE is a TWO step process:-
The first step is often referred as SOFTLOCK or DATABASE FREEZE- occurs after all data cleaning, validation, and QC activities have been finalized.
The second step is called HARDLOCK or DATABASE LOCK –At this stage the database is handed over to statistics for data analysis.
DATA TRANSFER
Traditional Data Transfer
CRFs developed by sponsor and supplied to the site along with completion/instruction manual .
Use a black or blue ball point pen for permanency – and PRESS HARD.
At the time of a monitoring visit, CRFs are reviewed for adherence to
guidelines and verified against source documents by the Monitor.
During the monitoring visit, site staff make required corrections to CRFs
Verified/corrected CRFs are submitted to the sponsor, leaving a legible
copy of the CRF at the site.
TSDP tells about the essential documents that are required for the #conduct of a clinical trial. For #regulatory medical writing training, contact hello@turacoz.in.
Explaining the importance of a database lock in clinical researchTrialJoin
One of the most crucial aspects of research is clinical data management or CDM. Proper CDM will generate results with excellent quality, integrity, and reliability. Quality data is essential in order to support the final conclusions of a certain study.
The person responsible for this area of research is called a clinical data manager. This job position can be filled by a PI, a study coordinator, or a CRA. No matter who fills this position at your site, data management has to be done promptly and correctly in order to generate the best results. Aside from all the other reasons why data management is so important, it’s also what determines the future IP (investigational product) development.
Clinical Data Management Plan_Katalyst HLSKatalyst HLS
Introduction to Data Management Plan in Clinical Data Management in Clinical Trials of Pharmaceuticals, Bio-Pharmaceuticals, Medical Devices, Cosmeceuticals and Foods.
Clinical data management (CDM) is a covered part in the clinical trial and most commonly used tools for the purpose of effectivity of clinical research
Electronic Data Capture & Remote Data CaptureCRB Tech
CRB Tech is one of the best leading Software Development Company in Pune. We are offering Software Development Services as well as IT Training including Java, Dot Net, SEO and Clinical Research training in pune.
How to prepare and handle a FDA Inspection. When the FDA conducts an audit of your company, you need to be prepared. This presentation shows you what to do when your are faced with a FDA Inspection. For more information go to http://compliance-insight.com/fda-483-warning-letters/fda-483-inspection/
In any work or process documents that are needed before initiation, Between or generally the end of the process just like in a clinical trial those “Documents which permit evaluation of the conduct of a trial and the quality of the data produced. It is given in the 8th section of the ICH-GCP.
CDM is defined as the process of collection, cleaning, and management of subject data in compliance with regulatory standards.
A database must be accurate, secure, reliable and ready for analysis.
CDMS is the tool for clinical data management.
RESPONSIBILITES OF CDM
STUDY SET UP (15%) - this includes all the activities that are done before at the starting of the study.
STUDY CONDUCT (60%)- this starts once a subject enrollment begins or with first patient‘s first visit.
STUDY CLOSEOUT (25%) -the data is final and ready for statistical analysis.
CASE REPORT FORM
Types of CRF
PAPER CRF
e-CRF
Data entry is a process of entering or transferring data from case report form ( paper or image ) to clinical data management system (electronic storage ).
optical mark reading (OMR)
Data entry may be entirely manual or partly computerized using optical character recognition (OCR).
The three basic types of data entry system:
(a) Local data entry system - data entry is done on site
(b) Central data entry system - data entry is done at data management centre from the received CRFs;
(c) Web based data entry system - data entry is done through web (secure link) using internet connection.
DATA CLEANING
MANAGING ADR DATA
ADR data are collected from clinical trials and marketed products.
All ADR are reported to clinical data management system or safety system.
During clinical trials-ADR information is also received through CRF or EDC.
These information are stored in clinical data management database.
DATABASE LOCK PROCESS
Data manager – data is accurate and complete
Clinical project manager – site activities are complete
Medical monitor - data is medically accurate
Biostatistician - data is ready for evaluation and analysis.
Data manager asks for the database to be locked .
Done through the company’s IT department.
Once locked, no data can be changed.
Signed process for locking the database is placed in Trial Master File (TMF)
Data base closure (database lock): The database closure for the study is done to ensure no manipulation of study data during final analysis.
DATABASE LOCK/FREEZE is a TWO step process:-
The first step is often referred as SOFTLOCK or DATABASE FREEZE- occurs after all data cleaning, validation, and QC activities have been finalized.
The second step is called HARDLOCK or DATABASE LOCK –At this stage the database is handed over to statistics for data analysis.
DATA TRANSFER
Traditional Data Transfer
CRFs developed by sponsor and supplied to the site along with completion/instruction manual .
Use a black or blue ball point pen for permanency – and PRESS HARD.
At the time of a monitoring visit, CRFs are reviewed for adherence to
guidelines and verified against source documents by the Monitor.
During the monitoring visit, site staff make required corrections to CRFs
Verified/corrected CRFs are submitted to the sponsor, leaving a legible
copy of the CRF at the site.
Top 100+ Google Data Science Interview Questions.pdfDatacademy.ai
Data science interviews can be particularly difficult due to the many proficiencies that you'll have to demonstrate (technical skills, problem solving, communication) and the generally high bar to entry for the industry.we Provide Top 100+ Google Data Science Interview Questions : All You Need to know to Crack it
visit by :-https://www.datacademy.ai/google-data-science-interview-questions/
Meeting the objectives of Meaningful Use is important for complying with government initiatives, but it is equally important for the practice to get the most practical use for their investment.
Success comes from enabling your workforce to make better decisions and execute appropriate actions. We deliver value to your Hospital or Clinic by helping you reduce the time, resources, effort, and cost of operating your Laboratory System.
Our Laboratory Information System is built on world class Sage 300 ERP award winning architecture. Lab System integrates with any HL7 compliant hospital information system. LIS follows CAP compliant (College of American Pathologists) and most of the hospitals were LIS is implemented are JCI (Joint Commission International).
clinical data management in clinical research, helpful for pharmacy, nursing, medical, health care providers, clinical research organization, PharmD, CROs, Clinical trial industry, human biomedical research.
Problem Statement:One of the common concerns from the customers is that how to effectively optimize the testing given the
multiple integration points in a distributed/composite system environments, which does expose at least the below
pain points:
1. Avoid Exhausted testing
2. Meet all the boundary conditions
3. Limited time to execute 100% test execution
4. Include all the critical business functions
5. Efficient Regression Testing
and the list goes on...
Resolution: The solution is detailed in the attachment and have effectively implemented in various client places.
Introduction to Aggregate Reporting in Drug Safety & Pharmacovigilance in Pharmaceuticals, Bio-Pharmaceuticals, Medical Devices, Cosmeceuticals and Foods.
Contact:
"Katalyst Healthcares & Life Sciences"
South Plainfield, NJ, USA
info@KatalystHLS.com
Overview of Validation in Pharma_Katalyst HLSKatalyst HLS
Introduction to Validation Concepts in Pharma, Bio-Pharma, Medical Device, Cosmetics, Food, Beverages industry.
Contact:
Katalyst Healthcare’s & Life Sciences
South Plainfield, NJ, USA 07080.
E-Mail: info@KatalystHLS.com
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
7. 7
Dates and Events
DATA
Medical
Terminologies
Numerical Data
Medical & General
abbreviations
DEO (Data Entry Operator) should be aware of:
- The kind of data to be entered
- Project specific guidelines & standard guidelines
- Good knowledge of the medical terms
8. Double Data Entry
CRFs received at Data
Management centre
First DEO performs tracking and
first pass data entry
Pages released from 1st pass and
ready for 2nd pass entry
Second pass entry performed by
2nd DEO
Operator
comments/ Manual
query raised
System generated
discrepancies
Mismatch entries
Second pass entry complete
NO
YES Comparison
Reconciliation
9. • Enter data from the CRF.
• Check if there are any
illegible text or problems in
the data. If so, create an
Operator Comment.
• Or check if there are any
investigator comments.
• If the investigator comment
exists enter data in the
investigator comment section.
• Else check for any System
generated errors.
• If discrepancies are found,
save the data with
discrepancy or re-enter the
correct value.
• Else exit entry.
21. Trend Observed:
Opening the CRF and database in one window
Toggling between windows (CRF, Database, DEI)
Cause:
Database development more tilted towards copying the CRF layout with
little importance given to the ease of entry during actual production
Remedial Action:
Database should be tested for ease of entry
before actual production
22. Trends Observed:
After completing process trainings, data entry associates either enter the
production directly or are shadowed for some time in actual production
Lack of typing skill – looking at the keyboard while typing
Cause:
Absence of mock database
Mock database not used even if present
RemedialActions:
Mock database should be developed for practice before entering
data in production database
DE associates should practice onTypingTutor
23. Data in the CRF – Infection 2-3 times
Data entered by DEO1 – Infection 2-3 times
Data entered by DEO2 – Infection2-3 times
Preventive Action :
Please ensure that appropriate spaces are left in between the words.
24. Data in the CRF – Response ticked in the CRF -Yes/Y
Data entered by DEO1(First Pass) – Yes/Y
Data entered by DEO2 (Second Pass) – No/N
Preventive Action :
Please be alert while doing DE, refrain from using ‘Tab’
25. Data in the CRF – Only 20ml of blood was drawn
Data entered by DEO1 – Only 20ml of blood was drawn
Data entered by DEO2 – Only 20ml blood was drawn
Preventive Action :
Please ensure adequate DE of each word as mentioned in the CRF
26. When data in the CRF is illegible, the DEOs will try their best to
decipher what has been written (and also issue a sponsor note for the
illegible data).
When captured as an error in the verification report, the TL – DE will
use his best discretion for analyzing the same and make appropriate
entry in the database.